PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 26141494-6 2015 RESULTS: In vitro binding potency for ixazomib to the hERG channel was weak (K i 24.9 muM; IC50 59.6 muM), and nonclinical telemetry studies showed no QT/QTc prolongation at doses up to 4.2 mg/m(2). ixazomib 38-46 latexin Homo sapiens 86-89 26141494-6 2015 RESULTS: In vitro binding potency for ixazomib to the hERG channel was weak (K i 24.9 muM; IC50 59.6 muM), and nonclinical telemetry studies showed no QT/QTc prolongation at doses up to 4.2 mg/m(2). ixazomib 38-46 latexin Homo sapiens 101-104